Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05732233

Ultivision AI CADe Randomized Controlled Trial

Conditions: Colon Adenoma, Polyp of Colon, Adenoma Colon

Sex: All
Ages: 45 Years – 75 Years
Phase: NA
Enrollment: 1100
Sponsor: Satisfai Health, Inc.

Location: United States

Summary

Ultivision AI is a computer-assisted detection (CADe) device intended to aid endoscopists in the real-time identification of colonic mucosal lesions (such as polyps and adenomas).Ultivision AI CADe is indicated for white light colonoscopy only.

Eligibility Criteria

Inclusion Criteria:Age 45 to 75 years;Screening or surveillance colonoscopy.Iinformed consentExclusion Criteria:Colorectal cancer;Inflammatory bowel disease, including Crohn's disease or ulcerative colitis;Polyposis syndrome including Familial Adenomatous Polyposis, Cowden syndome, Linch syndrome, Peutz-Jeghers syndrome, MUITYH associated polyposis, familial Colorectal Cancer type X;Positive Fecal Immunochemical Test;Use anti-platelet agents or anticoagulants that prevent polyps removal;Colon resection, not including the appendix;Subject is pregnant or lactating.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05732233). StuddyBuddy aggregates publicly available trial information.